NEA Management Company, LLC
CIK: 0001512848Latest portfolio: $2.0B · Q4 2025
Holdings
27
Total Value
$2.0B
New Positions
1
Closed Positions
2
Top Holdings
View All 27 Holdings →| # | Stock | Shares | Value | % Portfolio | Change | Type |
|---|---|---|---|---|---|---|
| 1 | CELCCelcuity Inc. | 3,535,561 | $352.6M | 17.98% | +1.4M | |
| 2 | RYTMRhythm Pharmaceuticals, Inc. | 2,909,956 | $311.5M | 15.88% | — | |
| 3 | ACLXArcellx, Inc. | 3,045,262 | $198.6M | 10.12% | — | |
| 4 | TRVITrevi Therapeutics, Inc. | 13,222,228 | $165.5M | 8.44% | — | |
| 5 | YB4PSavara, Inc. | 24,471,264 | $147.6M | 7.52% | — | |
| 6 | ZBIOZenas BioPharma, Inc. | 3,523,219 | $127.9M | 6.52% | +790K | |
| 7 | GLUEMonte Rosa Therapeutics, Inc. | 7,692,298 | $120.6M | 6.15% | — | |
| 8 | MBXMBX Biosciences, Inc. | 3,614,486 | $114.0M | 5.81% | — | |
| 9 | COURCoursera, Inc. | 12,867,769 | $94.7M | 4.83% | — | |
| 10 | AUPHAurinia Pharmaceuticals, Inc. | 3,969,834 | $63.3M | 3.23% | — | |
| 11 | GOSSGossamer Bio, Inc. | 18,093,034 | $56.1M | 2.86% | — | |
| 12 | CRSPCRISPR Therapeutics AG | 1,058,570 | $55.5M | 2.83% | — | |
| 13 | ORICORIC Pharmaceuticals, Inc. | 4,118,621 | $33.7M | 1.72% | — | |
| 14 | PHATPhathom Pharmaceauticals, Inc. | 1,960,169 | $32.5M | 1.66% | — | |
| 15 | CVRXCVRx, Inc. | 2,026,083 | $14.4M | 0.73% | — | |
| 16 | ASNSUSDX4 Pharmaceuticals, Inc. | 3,233,743 | $12.9M | 0.66% | +1.0M | |
| 17 | CSBRChampions Oncology, Inc. | 1,713,720 | $11.8M | 0.60% | — | |
| 18 | BDTXBlack Diamond Therapeutics, Inc. | 4,448,757 | $10.8M | 0.55% | — | |
| 19 | KRROKorro Bio, Inc. | 1,090,793 | $8.7M | 0.45% | — | |
| 20 | IVAInventiva SA | 1,462,586 | $6.8M | 0.35% | — | |
| 21 | NKTXNkarta, Inc. | 3,568,781 | $6.6M | 0.34% | — | |
| 22 | SNTISenti Biosciences, Inc. | 3,775,615 | $3.9M | 0.20% | — | |
| 23 | LONALeonaBio, Inc. | 464,398 | $3.5M | 0.18% | NEW | |
| 24 | SYBXSynlogic, Inc. | 2,922,772 | $3.3M | 0.17% | — | |
| 25 | MRKRMarker Therapeutics, Inc. | 1,625,678 | $2.4M | 0.12% | — |
Quarterly Changes
Sector Breakdown
Healthcare0.0% ($3.5263631148119856e+103T)
Unknown0.0% ($14.8T)
Consumer Defensive0.0% ($94.7M)
Technology0.0% ($3.3M)
Filing History
| Quarter | Filing Date | Portfolio Value | Holdings |
|---|---|---|---|
| Q4 2025 | Feb 17, 2026 | $2.0B | 27 |
| Q3 2025 | Nov 14, 2025 | $1.8T | 29 |
| Q2 2025 | Aug 14, 2025 | $1.3T | 32 |
| Q1 2025 | May 14, 2025 | $1.3T | 38 |
| Q4 2024 | Feb 14, 2025 | $1.8T | 42 |
| Q3 2024 | Nov 14, 2024 | $1835.6T | 42 |
| Q2 2024 | Aug 14, 2024 | $1329.0T | 41 |
| Q1 2024 | May 15, 2024 | $1611.0T | 44 |
| Q4 2023 | Feb 14, 2024 | $1500.4T | 44 |
| Q3 2023 | Nov 14, 2023 | $1294.9T | 46 |
| Q2 2023 | Aug 11, 2023 | $1310.0T | 44 |
| Q1 2023 | May 15, 2023 | $1446.7T | 53 |
| Q4 2022 | Feb 10, 2023 | $1779.5T | 57 |
| Q3 2022 | Nov 14, 2022 | $2.0T | 57 |
| Q2 2022 | Aug 15, 2022 | $1.9T | 57 |
| Q1 2022 | May 16, 2022 | $3.5T | 57 |
| Q4 2021 | Feb 14, 2022 | $4.9T | 58 |
| Q3 2021 | Nov 12, 2021 | $8.4T | 63 |
| Q2 2021 | Aug 2, 2021 | $7.7T | 63 |
| Q1 2021 | May 14, 2021 | $4.5T | 58 |
| Q4 2020 | Feb 16, 2021 | $3.8T | 57 |
| Q3 2020 | Nov 6, 2020 | $2.4T | 54 |
| Q2 2020 | Aug 5, 2020 | $2.5T | 46 |
| Q1 2020 | May 6, 2020 | $1.9T | 50 |
| Q4 2019 | Jan 24, 2020 | $2.1T | 47 |
| Q3 2019 | Oct 11, 2019 | $1.2T | 46 |
| Q2 2019 | Aug 7, 2019 | $1.4T | 44 |
| Q1 2019 | May 8, 2019 | $1.9T | 45 |
| Q4 2018 | Jan 18, 2019 | $2.5T | 46 |
| Q3 2018 | Nov 13, 2018 | $2.3T | 44 |
| Q2 2018 | Aug 9, 2018 | $2.1T | 43 |
| Q1 2018 | May 10, 2018 | $2.2T | 43 |
| Q4 2017 | Feb 8, 2018 | $2.4T | 43 |
| Q3 2017 | Nov 3, 2017 | $2.9T | 44 |
| Q2 2017 | Jul 26, 2017 | $2.7T | 44 |
| Q1 2017 | May 10, 2017 | $2.9T | 38 |
| Q4 2016 | Feb 9, 2017 | $2.5T | 39 |
| Q3 2016 | Nov 10, 2016 | $2.2T | 39 |
| Q2 2016 | Aug 5, 2016 | $1.9T | 39 |
| Q1 2016 | May 11, 2016 | $1.5T | 37 |
Fund Information
NEA Management Company, LLC is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $2.0B across 27 holdings. The largest position is Celcuity Inc. (CELC), representing 18.0% of the portfolio. Compared to the previous quarter, the fund opened 1 new positions and closed 3 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.